Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 213,645 | 101,136 | 57,841 | 125,166 | 66,449 |
| Marketable Securities | 211,093 | 53,153 | 63,001 | 16,107 | 94,468 |
| Other current assets | 0 | 300,000 | 0 | 0 | 0 |
| TOTAL | $429,824 | $459,562 | $123,953 | $144,672 | $165,315 |
| Non-Current Assets | |||||
| PPE Net | 16,943 | 17,563 | 18,346 | 19,002 | 19,493 |
| Other Non-Current Assets | 41,538 | 42,649 | 43,770 | 44,852 | 45,078 |
| TOTAL | $58,481 | $60,212 | $62,116 | $63,854 | $64,571 |
| Total Assets | $488,305 | $519,774 | $186,069 | $208,526 | $229,886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,071 | 3,819 | 3,821 | 3,406 | 2,911 |
| Accrued Expenses | 7,010 | 9,562 | 7,206 | 5,152 | 5,126 |
| TOTAL | $48,243 | $48,692 | $19,296 | $16,414 | $16,332 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 19,914 | 19,826 | 19,739 |
| Deferred Revenues | 30,059 | 28,317 | 1,278 | 910 | 2,407 |
| Other Non-Current Liabilities | 50,593 | 51,481 | 53,191 | 54,803 | 56,548 |
| TOTAL | $367,661 | $374,211 | $85,791 | $87,922 | $88,390 |
| Total Liabilities | $415,904 | $422,903 | $105,087 | $104,336 | $104,722 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,468 | 41,422 | 37,092 | 36,937 | 36,846 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -291,170 | -264,256 | -235,113 | -209,033 | -185,922 |
| Other shareholders' equity | -1,194 | -10 | -13 | -10 | 6 |
| TOTAL | $72,401 | $96,871 | $80,982 | $104,190 | $125,164 |
| Total Liabilities And Equity | $488,305 | $519,774 | $186,069 | $208,526 | $229,886 |